Maccura Biotechnology (China) Performance
| 300463 Stock | 13.94 0.07 0.50% |
On a scale of 0 to 100, Maccura Biotechnology holds a performance score of 8. The company secures a Beta (Market Risk) of -0.47, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Maccura Biotechnology are expected to decrease at a much lower rate. During the bear market, Maccura Biotechnology is likely to outperform the market. Please check Maccura Biotechnology's downside deviation, information ratio, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Maccura Biotechnology's current price movements will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Maccura Biotechnology Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maccura Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.011 | Payout Ratio 0.4606 | Last Split Factor 30:10 | Forward Dividend Rate 0.15 | Ex Dividend Date 2024-07-03 |
1 | Is Maccura Biotechnology Co.Ltds Recent Price Movement Underpinned By Its Weak Fundamentals - Simply Wall St | 08/23/2024 |
2 | Maccura BiotechnologyLtds earnings trajectory could turn positive as the stock rallies 4.2 percent this past week - Simply Wall St | 11/13/2024 |
| Begin Period Cash Flow | 564.3 M |
Maccura |
Maccura Biotechnology Relative Risk vs. Return Landscape
If you would invest 1,176 in Maccura Biotechnology Co on August 28, 2024 and sell it today you would earn a total of 225.00 from holding Maccura Biotechnology Co or generate 19.13% return on investment over 90 days. Maccura Biotechnology Co is generating 0.3551% of daily returns and assumes 3.3202% volatility on return distribution over the 90 days horizon. Simply put, 29% of stocks are less volatile than Maccura, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Maccura Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Maccura Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Maccura Biotechnology Co, and traders can use it to determine the average amount a Maccura Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.107
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300463 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.32 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Maccura Biotechnology is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Maccura Biotechnology by adding it to a well-diversified portfolio.
Maccura Biotechnology Fundamentals Growth
Maccura Stock prices reflect investors' perceptions of the future prospects and financial health of Maccura Biotechnology, and Maccura Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Maccura Stock performance.
| Return On Equity | 0.0485 | ||||
| Return On Asset | 0.0219 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 8.38 B | ||||
| Shares Outstanding | 612.47 M | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 3.16 X | ||||
| Revenue | 2.9 B | ||||
| Gross Profit | 1.96 B | ||||
| EBITDA | 613.34 M | ||||
| Net Income | 312.62 M | ||||
| Total Debt | 144.65 M | ||||
| Book Value Per Share | 10.79 X | ||||
| Cash Flow From Operations | 901.51 M | ||||
| Earnings Per Share | 0.53 X | ||||
| Total Asset | 8.12 B | ||||
| Retained Earnings | 3.84 B | ||||
About Maccura Biotechnology Performance
By analyzing Maccura Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Maccura Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Maccura Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Maccura Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Maccura Biotechnology is entity of China. It is traded as Stock on SHE exchange.Things to note about Maccura Biotechnology performance evaluation
Checking the ongoing alerts about Maccura Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Maccura Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Maccura Biotechnology had very high historical volatility over the last 90 days | |
| Maccura Biotechnology is unlikely to experience financial distress in the next 2 years | |
| About 40.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Maccura BiotechnologyLtds earnings trajectory could turn positive as the stock rallies 4.2 percent this past week - Simply Wall St |
- Analyzing Maccura Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Maccura Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Maccura Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Maccura Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Maccura Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Maccura Biotechnology's stock. These opinions can provide insight into Maccura Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Maccura Stock analysis
When running Maccura Biotechnology's price analysis, check to measure Maccura Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maccura Biotechnology is operating at the current time. Most of Maccura Biotechnology's value examination focuses on studying past and present price action to predict the probability of Maccura Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maccura Biotechnology's price. Additionally, you may evaluate how the addition of Maccura Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |